The Coalition on Abortion/Breast Cancer applauds the breast cancer group, Susan G. Komen for the Cure, for discontinuing its grants to Planned Parenthood (PP) while the abortion provider is under investigation by Congress. Komen said it will not resume payment of the grants unless PP is exonerated. Komen attributed its decision to a new policy that prohibits grants from going to organizations under investigation by governmental authorities.
“Our group will remain as Komen’s critic as long as it continues to work against its own mission to eradicate breast cancer. Komen’s decision is a step in the right direction to protect women’s lives. However, I will not donate to Komen while it is still cooperating in the cover-up of the abortion-breast cancer link and downplaying the risk of using oral contraceptives (OCs).” asserted Karen Malec, president of the Coalition on Abortion/Breast Cancer.
“PP is a primary cause of the breast cancer epidemic. It sells cancer-causing abortions and oral contraceptives (OCs), also called “the birth control pill.” Medical texts reveal that increased childbearing, especially starting early before age 24, substantially reduces lifetime breast cancer risk. Abortion not only deprives women of this protection, but 52 of 68 epidemiological studies show it raises breast cancer risk. The World Health Organization lists OCs containing estrogen and progesterone on its list of Group 1 carcinogens – the highest level as a cancer-causing agent.  OCs are associated with the deadly triple-negative breast cancer. [3,4] Komen and the Institute of Medicine had an opportunity to reduce the incidence of breast cancer with its December 2011 study, “Breast Cancer and the Environment,” but they chose not to review reproductive risk factors and include avoidance of abortion and OCs among the ways to prevent the disease. We sincerely hope Komen will develop the political courage needed to fulfill its mission.
“PP has done substantial harm to women’s health. Additionally, PP does not do mammograms, although PP president Cecile Richards had led the public to believe otherwise.
“The Coalition on Abortion/Breast Cancer was the first to expose the Komen-PP relationship to the world in 2003. We thank our supporters for doing such a marvelous job by contacting Komen and stating their objections to this irregular relationship, and we remind them their work is not yet done. Contact Komen at ww5.komen.org/Contact.aspx. Politely thank Komen’s representatives for temporarily halting its gifts to Planned Parenthood. Ask them to permanently halt their grants to PP and tell the full truth about the breast cancer risks associated with induced abortion and oral contraceptives.”
The Coalition on Abortion/Breast Cancer is an international women’s organization founded to protect the health and save the lives of women by educating and providing information on abortion as a risk factor for breast cancer.
1. See the Breast Cancer Prevention Institute’s website for a complete list of all epidemiological studies and the odds ratios reported for each at: http://bcpinstitute.org/epidemiology_studies_bcpi.htm
2. Cogliano V, Grosse Y, Baan R, Secretan B, El Ghissassi F. Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment. Lancet Oncology 2005;6:552-553.
3. Dolle J, Daling J, White E, Brinton L, Doody D, et al. Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev 2009;18(4)1157-1166. Available at: http://www.abortionbreastcancer.com/download/Abortion_Breast_Cancer_Epid_Bio_Prev_2009.pdf
4. Ma H, Wang Y, Sullivan-Halley J, Weiss, L, Marchbanks, PA, et al. Use of four biomarkers to evaluate the risk of breast cancer subtypes in the Women’s Contraceptive and Reproductive Experiences Study. Cancer Research 2010;70(2):575-587.